Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2012 Nov 29;367(22):2154; author reply 2155-6.
doi: 10.1056/NEJMc1210001.

Multidrug-resistant tuberculosis

Lia D'Ambrosio, Rosella Centis, Giovanni B Migliori
Comment

Multidrug-resistant tuberculosis

Lia D'Ambrosio et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

Comment on

  • Delamanid for multidrug-resistant pulmonary tuberculosis.
    Gler MT, Skripconoka V, Sanchez-Garavito E, Xiao H, Cabrera-Rivero JL, Vargas-Vasquez DE, Gao M, Awad M, Park SK, Shim TS, Suh GY, Danilovits M, Ogata H, Kurve A, Chang J, Suzuki K, Tupasi T, Koh WJ, Seaworth B, Geiter LJ, Wells CD. Gler MT, et al. N Engl J Med. 2012 Jun 7;366(23):2151-60. doi: 10.1056/NEJMoa1112433. N Engl J Med. 2012. PMID: 22670901 Clinical Trial.
  • Confronting multidrug-resistant tuberculosis.
    Chaisson RE, Nuermberger EL. Chaisson RE, et al. N Engl J Med. 2012 Jun 7;366(23):2223-4. doi: 10.1056/NEJMe1204478. N Engl J Med. 2012. PMID: 22670908 No abstract available.

References

    1. Gler MT, Skripconoka V, Sanchez-Garavito E, et al. Delamanid for multidrug-resistant pulmonary tuberculosis. N Engl J Med. 2012;366:2151–60. - PubMed
    1. Raviglione M, Marais B, Floyd K, et al. Scaling up interventions to achieve global tuberculosis control: progress and new developments. Lancet. 2012;379:1902–13. - PubMed
    2. Lancet. 2012;379:2242. Erratum.
    1. Chaisson RE, Nuermberger EL. Confronting multidrug-resistant tuberculosis. N Engl J Med. 2012;366:2223–4. - PubMed
    1. Migliori GB, Langendam MW, D’Ambrosio L, et al. Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones. Eur Respir J. 2012;40:814–22. - PMC - PubMed
    1. van der Werf MJ, Langendam MW, Huitric E, Manissero D. Multidrug resistance after inappropriate tuberculosis treatment: a meta-analysis. Eur Respir J. 2012;39:1511–9. - PMC - PubMed

MeSH terms